Chronic Traumatic Encephalopathy (CTE)

Migration, Crosslink

📖

Chronic Traumatic Encephalopathy (CTE)

active

wiki page Created: 2026-04-02T07:20:12 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-chronic-traumatic-encephal

📖 Wiki Page

disease1415 wordssynced 2026-04-02

Chronic Traumatic Encephalopathy (CTE)

Overview

Chronic Traumatic Encephalopathy is a progressive neurodegenerative disease associated with repetitive traumatic brain injury (TBI), most commonly seen in contact sport athletes and military veterans. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.

Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease caused by repetitive traumatic brain injury (TBI), most commonly associated with contact sports, military service, and physical abuse[@mckee2009]. CTE is characterized by the accumulation of hyperphosphorylated tau (p-tau) protein in the form of neurofibrillary tangles (NFTs), predominantly affecting cortical neurons and leading to progressive cognitive, behavioral, and motor impairments[@omalu2005].

Epidemiology and Risk Factors

Prevalence

CTE has been predominantly identified in individuals with a history of repetitive mild traumatic brain injuries:

Contact sport athletes: American football players, boxers, hockey players, soccer players, and rugby players show the highest prevalence
Military veterans: Those exposed to blast injuries and repetitive concussive events
Physical abuse victims: Individuals with a history of repeated head trauma

...

Chronic Traumatic Encephalopathy (CTE)

Overview

Chronic Traumatic Encephalopathy is a progressive neurodegenerative disease associated with repetitive traumatic brain injury (TBI), most commonly seen in contact sport athletes and military veterans. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.

Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease caused by repetitive traumatic brain injury (TBI), most commonly associated with contact sports, military service, and physical abuse[@mckee2009]. CTE is characterized by the accumulation of hyperphosphorylated tau (p-tau) protein in the form of neurofibrillary tangles (NFTs), predominantly affecting cortical neurons and leading to progressive cognitive, behavioral, and motor impairments[@omalu2005].

Epidemiology and Risk Factors

Prevalence

CTE has been predominantly identified in individuals with a history of repetitive mild traumatic brain injuries:

Contact sport athletes: American football players, boxers, hockey players, soccer players, and rugby players show the highest prevalence
Military veterans: Those exposed to blast injuries and repetitive concussive events
Physical abuse victims: Individuals with a history of repeated head trauma

The disease typically manifests decades after the period of repetitive brain trauma, with onset usually occurring in middle to late adulthood[@mez2017]. A 2017 study of 202 former American football players found CTE in 177 (87%) of brains donated to the CTE Center at Boston University.

Risk Factors

Duration of exposure: Number of years participating in contact sports
Number of concussions: Total lifetime concussive and subconcussive impacts
Age of first exposure: Earlier age of initial head trauma exposure correlates with worse outcomes
Genetic factors: APOE ε4 allele may increase susceptibility[@mayeux2015]

Pathophysiology

Tau Pathology

CTE is defined pathologically by the presence of hyperphosphorylated tau protein NFTs in a pattern distinct from other tauopathies[@mckee2013]:

Distribution: Initially affects the superficial cortical layers (II-III), then spreads to deeper layers
Regional pattern: Preferentially affects frontal and temporal cortices, with relative sparing of the hippocampus early in disease
Perivascular pattern: p-tau aggregates around blood vessels, particularly in the depths of cortical sulci
Neuronal preference: Affects neurons preferentially over glial cells, unlike chronic traumatic encephalomyelopathy
Astrocytic tau: Astrocytic tau pathology is a characteristic feature

Mechanistic Pathways

Mermaid diagram (expand to render)

Molecular Mechanisms

Axonal damage: Mechanical disruption of microtubules leads to impaired axonal transport

Neuroinflammation: Chronic microglial activation and neuroinflammation

Blood-brain barrier disruption: Increased permeability following repeated injuries

Tau kinases activation: Chronic activation of GSK-3β, CDK5, and MAPK pathways

Oxidative stress: Increased reactive oxygen species generation following repeated injuries

Excitotoxicity: Release of excitatory neurotransmitters leads to calcium influx and neuronal dysfunction

Amyloid Co-Pathology

While CTE is primarily a tauopathy, approximately 20-50% of CTE cases also show co-existing amyloid-beta plaques, similar to Alzheimer's disease. This overlap suggests common pathogenic mechanisms or that repetitive brain trauma may accelerate Alzheimer's-type pathology in susceptible individuals.

Clinical Presentation

Clinical Staging

CTE symptoms typically develop years to decades after the period of repetitive brain trauma:

| Stage | Symptoms |
|-------|----------|
| Stage I | Headache, attention deficits, irritability, mood changes |
| Stage II | Memory loss, impulsivity, aggression, anxiety |
| Stage III | Severe memory loss, parkinsonism, speech abnormalities |
| Stage IV | Dementia, severe motor impairment, psychosis |

Cognitive Impairments

Memory loss and difficulty forming new memories
Executive dysfunction and impaired judgment
Attention and concentration deficits
Progressive dementia

Behavioral Changes

Mood swings and irritability
Depression and anxiety
Impulse control problems
Aggression and explosive temper
Suicidal ideation

Motor Symptoms

Parkinsonism and gait disturbances
Dysarthria (slurred speech)
Muscle weakness and atrophy
Tremor and rigidity

Other Features

Chronic traumatic encephalomyelopathy (CTEM): Combined tau and motor neuron pathology
Progressive dysphagia (difficulty swallowing)
Sleep disturbances including REM sleep behavior disorder

Diagnosis

Clinical Criteria

Currently, CTE can only be diagnosed definitively at autopsy. Proposed clinical criteria include:

History: Documented exposure to repetitive brain trauma

Core clinical features: Progressive cognitive/behavioral/motor impairment

Red flags: Psychiatric symptoms, headache, sensory changes

Biomarkers (In Development)

Neurofilament light chain (NfL): Elevated in CSF and blood
Tau species: Total tau and phosphorylated tau in CSF
PET imaging: Tau ligands (e.g., [^18F]AV-1451) showing characteristic patterns
Neuroimaging: MR spectroscopy showing reduced N-acetylaspartate

Differential Diagnosis

Alzheimer's disease
Frontotemporal dementia
Parkinson's disease
Progressive supranuclear palsy
Corticobasal degeneration
Amyotrophic lateral sclerosis (when co-occurring)

Management

Current Approaches

There is no disease-modifying therapy for CTE. Management focuses on symptom relief:

Cognitive/Behavioral:

Acetylcholinesterase inhibitors (donepezil, rivastigmine)
Memantine for cognitive symptoms
Selective serotonin reuptake inhibitors (SSRIs) for depression
Antipsychotics for severe behavioral disturbances

Motor Symptoms:

Levodopa for parkinsonism
Physical therapy
Speech therapy for dysarthria

Preventive Strategies

Rule changes: Reducing head-to-head contact in sports
Equipment: Improved helmets and mouthguards
Technique: Teaching proper tackling and heading techniques
Return-to-play protocols: Strict concussion management
Limiting exposure: Reducing contact sport participation in youth

Research and Clinical Trials

Active Research Areas

Biomarker development: Identifying in vivo diagnostic markers
Neuropathology: Characterizing CTE staging and variants
Genetic susceptibility: Identifying risk genes (e.g., APOE ε4)
Therapeutic targets: Developing disease-modifying treatments

Key Research Centers

| Center | Location |
|--------|----------|
| BU CTE Center | Boston University |
| VA-BU-CLF Brain Bank | Boston, MA |
| NIH CTE Program | National Institutes of Health |

Emerging Therapies

Tau immunotherapy: Active and passive immunization against tau
Tau aggregation inhibitors: Small molecules targeting p-tau formation
Neuroprotective agents: Compounds promoting neuronal survival
Anti-inflammatory therapies: Targeting chronic neuroinflammation

Cross-References

Tau Pathology
[Neuroinflammation](/mechanisms/neuroinflammation)
Axonal Transport Defects
Traumatic Brain Injury Mechanisms

[MAPT](/mechanisms/dopaminergic-neuron-vulnerability)
[APOE](/genes/apoe)

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
[Cerebral Amyloid Angiopathy](/gaps/cerebral-amyloid-angiopathy-ad)

Prefrontal Cortex - Early affected region
Locus Coeruleus - Noradrenergic dysfunction
Cerebral Cortex - Core affected region

Key Publications

[McKee et al., The spectrum of disease in chronic traumatic encephalopathy (2013)](https://pubmed.ncbi.nlm.nih.gov/23333407/). Brain. 2013;136(Pt 1):43-64.

[Mez et al., Clinicopathological Evaluation of CTE in Players of American Football (2017)](https://pubmed.ncbi.nlm.nih.gov/28679853/). JAMA. 2017;318(4):360-370.

[Stein et al., Chronic traumatic encephalopathy: a spectrum of neuropathological changes (2014)](https://pubmed.ncbi.nlm.nih.gov/24439377/). Acta Neuropathol. 2014;127(1):13-15.

[Stern et al., Clinical Presentation of CTE (2013)](https://pubmed.ncbi.nlm.nih.gov/23474771/). Neurology. 2013;81(13):1122-1129.

[Turner et al., Defining the Spectrum of Long-Term sequelae (2021)](https://doi.org/10.1212/WNL.0000000000013050)

Recent Research (2024-2026)

[Inflammation, Limbic White Matter Microstructure, and Clinical Symptoms in Retired American Football Players (2026)](https://pubmed.ncbi.nlm.nih.gov/41740080/) - Neurology
[Retired contact sports athletes with cognitive concerns: promoting lifelong brain health (2026)](https://pubmed.ncbi.nlm.nih.gov/41062271/) - Practical neurology
[On media and messaging: fighting fear with facts as the science of CTE evolves (2026)](https://pubmed.ncbi.nlm.nih.gov/41571435/) - British Journal of Sports Medicine
[Motivation and methods for a first population-based case-control study of TBI and CTE (2026)](https://pubmed.ncbi.nlm.nih.gov/40987505/) - British Journal of Sports Medicine
[Effect of site-specific lysine acetylation on tau binding to microtubules (2026)](https://pubmed.ncbi.nlm.nih.gov/41738377/) - Physical Chemistry Chemical Physics

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Allen Brain Atlas Resources

[Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
[Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
[Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

[McKee et al., Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19587364/)

[Omalu et al., Chronic traumatic encephalopathy in a National Football League player (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15959414/)

[Mez et al., Clinicopathological Evaluation of CTE in Players of American Football (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28679853/)

[Unknown, Mayeux and Schupf, Apolipoprotein E and Alzheimer's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25993323/)

[McKee et al., The spectrum of disease in CTE (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23333407/)

[Blennow et al., Neurobiology of CTE (2016) (2016)](https://doi.org/10.1016/S1474-4422(16)

[Kelley et al., Tau pathology in CTE (2022) (2022)](https://doi.org/10.1002/alz.12608)

[Washington et al., CTE Neuropathology (2022) (2022)](https://doi.org/10.1007/s00401-022-02408-3)

[Alosco et al., Clinical phenotype of CTE (2018) (2018)](https://doi.org/10.1212/WNL.0000000000005518)

[Mez et al., Association between American football playing and CTE (2020) (2020)](https://doi.org/10.1001/jama.2019.21096)

📖 View canonical wiki page →

Related Entities

diseases-chronic-traumatic-encephalopathy

▸Metadataorigin_type: v1_polymorphic_backfill

slug	diseases-chronic-traumatic-encephalopathy
kg_node_id	None
entity_type	disease
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-5bf80a5cfa4c
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'diseases-chronic-traumatic-encephalopathy'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

25

Outgoing

31

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Chronic Traumatic Encephalopathy (CTE)

Chronic Traumatic Encephalopathy (CTE)

Overview

Epidemiology and Risk Factors

Prevalence

Chronic Traumatic Encephalopathy (CTE)

Overview

Epidemiology and Risk Factors

Prevalence

Risk Factors

Pathophysiology

Tau Pathology

Mechanistic Pathways

Molecular Mechanisms

Amyloid Co-Pathology

Clinical Presentation

Clinical Staging

Cognitive Impairments

Behavioral Changes

Motor Symptoms

Other Features

Diagnosis

Clinical Criteria

Biomarkers (In Development)

Differential Diagnosis

Management

Current Approaches

Preventive Strategies

Research and Clinical Trials

Active Research Areas

Key Research Centers

Emerging Therapies

Cross-References

Related Mechanisms

Related Proteins

Related Diseases

Related Brain Regions

Key Publications

Recent Research (2024-2026)

See Also

External Links

Allen Brain Atlas Resources

References

💬 Discussion